Bio Protocol vs Izumi Finance — how do they compare? Bio Protocol trades at Rp515.13 (market cap Rp1,15T, Rp256,3M 24h volume), while Izumi Finance trades at Rp26.85 (market cap Rp32,06M, Rp254,85jt 24h volume). The key difference: Bio Protocol is far larger — about 35870.2× Izumi Finance's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 787,4M / 2B IZI (40%) for Izumi Finance. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Izumi Finance for 10 Days on average.
| BIO | IZI | |
|---|---|---|
Market Cap | Rp1,15T | Rp32,06M |
Volume (24h) | Rp256,3M | Rp254,85jt |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 787,4M / 2B IZI (40%) |
Typical Hold Time | 16 Days | 10 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Izumi Finance provides Programmable Liquidity as a Service (LaaS) on Ethereum with Uniswap V3 and plans to expand to multiple chains with integrated DEXs. This service allows liquidity providers to earn extra liquidity mining rewards and trading fees. It also helps protocols attract and maintain liquidity effectively. Izumi improves incentive distribution through its LiquidBox, allowing rewards to be allocated within specific price ranges.
Read more on IZI →